Aldurazyme er blevet undersøgt hos 45 patienter i alderen fem år og derover med den bekræftede diagnose mucopolysaccharidosis I (MPS I).
Aldurazyme has been studied in 45 patients aged five years and over with a confirmed diagnosis of MPS I.